486 related articles for article (PubMed ID: 28827321)
1. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 co-chaperones, FKBP52 and Aha1, promote tau pathogenesis in aged wild-type mice.
Criado-Marrero M; Gebru NT; Blazier DM; Gould LA; Baker JD; Beaulieu-Abdelahad D; Blair LJ
Acta Neuropathol Commun; 2021 Apr; 9(1):65. PubMed ID: 33832539
[TBL] [Abstract][Full Text] [Related]
3. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
5. Hsp90 Oligomers Interacting with the Aha1 Cochaperone: An Outlook for the Hsp90 Chaperone Machineries.
Lepvrier E; Moullintraffort L; Nigen M; Goude R; Allegro D; Barbier P; Peyrot V; Thomas D; Nazabal A; Garnier C
Anal Chem; 2015 Jul; 87(14):7043-51. PubMed ID: 26076190
[TBL] [Abstract][Full Text] [Related]
6. Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
Woo JA; Liu T; Zhao X; Trotter C; Yrigoin K; Cazzaro S; Narvaez E; Khan H; Witas R; Bukhari A; Makati K; Wang X; Dickey C; Kang DE
Hum Mol Genet; 2017 Oct; 26(20):3973-3988. PubMed ID: 29016855
[TBL] [Abstract][Full Text] [Related]
7. Aha1 can act as an autonomous chaperone to prevent aggregation of stressed proteins.
Tripathi V; Darnauer S; Hartwig NR; Obermann WM
J Biol Chem; 2014 Dec; 289(52):36220-8. PubMed ID: 25378400
[TBL] [Abstract][Full Text] [Related]
8. Imbalances in the Hsp90 Chaperone Machinery: Implications for Tauopathies.
Shelton LB; Koren J; Blair LJ
Front Neurosci; 2017; 11():724. PubMed ID: 29311797
[TBL] [Abstract][Full Text] [Related]
9. Management of Hsp90-Dependent Protein Folding by Small Molecules Targeting the Aha1 Co-Chaperone.
Singh JK; Hutt DM; Tait B; Guy NC; Sivils JC; Ortiz NR; Payan AN; Komaragiri SK; Owens JJ; Culbertson D; Blair LJ; Dickey C; Kuo SY; Finley D; Dyson HJ; Cox MB; Chaudhary J; Gestwicki JE; Balch WE
Cell Chem Biol; 2020 Mar; 27(3):292-305.e6. PubMed ID: 32017918
[TBL] [Abstract][Full Text] [Related]
10. Modulation of the cochaperone AHA1 regulates heat-shock protein 90 and endothelial NO synthase activation by vascular endothelial growth factor.
Desjardins F; Delisle C; Gratton JP
Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2484-92. PubMed ID: 22859491
[TBL] [Abstract][Full Text] [Related]
11. Accelerated neurodegeneration through chaperone-mediated oligomerization of tau.
Blair LJ; Nordhues BA; Hill SE; Scaglione KM; O'Leary JC; Fontaine SN; Breydo L; Zhang B; Li P; Wang L; Cotman C; Paulson HL; Muschol M; Uversky VN; Klengel T; Binder EB; Kayed R; Golde TE; Berchtold N; Dickey CA
J Clin Invest; 2013 Oct; 123(10):4158-69. PubMed ID: 23999428
[TBL] [Abstract][Full Text] [Related]
12. Tau triage decisions mediated by the chaperone network.
Cook C; Petrucelli L
J Alzheimers Dis; 2013; 33 Suppl 1():S145-51. PubMed ID: 22596270
[TBL] [Abstract][Full Text] [Related]
13. Zn
Li X; Du X; Ni J
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30678122
[TBL] [Abstract][Full Text] [Related]
14. Small Heat Shock Protein 22 Improves Cognition and Learning in the Tauopathic Brain.
Rodriguez Ospina S; Blazier DM; Criado-Marrero M; Gould LA; Gebru NT; Beaulieu-Abdelahad D; Wang X; Remily-Wood E; Chaput D; Stevens S; Uversky VN; Bickford PC; Dickey CA; Blair LJ
Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35055033
[TBL] [Abstract][Full Text] [Related]
15. Tau neurotoxicity and rescue in animal models of human Tauopathies.
Krüger L; Mandelkow EM
Curr Opin Neurobiol; 2016 Feb; 36():52-8. PubMed ID: 26431808
[TBL] [Abstract][Full Text] [Related]
16. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
Blair LJ; Sabbagh JJ; Dickey CA
Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
[TBL] [Abstract][Full Text] [Related]
17. A novel C-terminal homologue of Aha1 co-chaperone binds to heat shock protein 90 and stimulates its ATPase activity in Entamoeba histolytica.
Singh M; Shah V; Tatu U
J Mol Biol; 2014 Apr; 426(8):1786-98. PubMed ID: 24486610
[TBL] [Abstract][Full Text] [Related]
18. Human cyclophilin 40 unravels neurotoxic amyloids.
Baker JD; Shelton LB; Zheng D; Favretto F; Nordhues BA; Darling A; Sullivan LE; Sun Z; Solanki PK; Martin MD; Suntharalingam A; Sabbagh JJ; Becker S; Mandelkow E; Uversky VN; Zweckstetter M; Dickey CA; Koren J; Blair LJ
PLoS Biol; 2017 Jun; 15(6):e2001336. PubMed ID: 28654636
[TBL] [Abstract][Full Text] [Related]
19. Phosphorylation and oligomerization of α-synuclein associated with GSK-3β activation in the rTg4510 mouse model of tauopathy.
Takaichi Y; Chambers JK; Inoue H; Ano Y; Takashima A; Nakayama H; Uchida K
Acta Neuropathol Commun; 2020 Jun; 8(1):86. PubMed ID: 32560668
[TBL] [Abstract][Full Text] [Related]
20. Tau phosphorylation, molecular chaperones, and ubiquitin E3 ligase: clinical relevance in Alzheimer's disease.
Kumar P; Jha NK; Jha SK; Ramani K; Ambasta RK
J Alzheimers Dis; 2015; 43(2):341-61. PubMed ID: 25096626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
